CBM News and Press, Cambrex Corporation From 09/23/19

EAST RUTHERFORD, N.J., Sept. 23, 2019 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE: CBM) (the “Company” or “Cambrex”) today announced the expiration, as of 12:01 a.m., Eastern Time, on September 22, 2019, of the 45-day “go shop” period under the pr...

NEW YORK, NY / ACCESSWIRE / September 20, 2019 / Juan Monteverde , founder and managing partner at Monteverde & Associates PC , a national securities firm headquartered at the Empire State Building in New York City, is investigating: Cambrex Corporation ( CBM ) ("Cambrex")...

NEW YORK, NY / ACCESSWIRE / September 10, 2019 / Juan Monteverde , founder and managing partner at Monteverde & Associates PC , a national securities firm headquartered at the Empire State Building in New York City, is investigating: Cambrex Corporation (NYSE: ...

NEW YORK, NY / ACCESSWIRE / August 15, 2019 / Juan Monteverde , founder and managing partner at Monteverde & Associates PC , a national securities firm headquartered at the Empire State Building in New York City, is investigating: ...

Merger activity increased last week with seven new deals announced and four pending deals closing. In the context of the merger of Sprint (S) with T-Mobile (TMUS), it was interesting to see a large insider purchase by the Chairman of DISH Network (DISH). Deal Statistics: New Deals: ...

NEW YORK , Aug. 9, 2019 /PRNewswire/ -- Juan Monteverde , founder and managing partner at Monteverde & Associates PC , a national securities firm headquartered at the Empire State Building in New York City , is investigating: Genomic Health, Inc. ( GHDX ) ("Genomic"...

Cambrex (NYSE: CBM ) is scheduled to announce Q2 earnings results on Friday, August 9th, before market open. The consensus EPS Estimate is $0.43 (-41.9% Y/Y) and the consensus Revenue Estimate is $156.44M (+2.9% Y/Y). Over the last 2 years, CBM  has beaten EPS estimates 63% of th...

EAST RUTHERFORD, N.J., Aug. 07, 2019 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE: CBM), the leading small molecule company providing drug substance, drug product and analytical services across the entire drug lifecycle, today announced that it will not hold a second quarter 2019 earnings ...

Gainers:  Cambrex Corporation (NYSE: CBM ) +47% . Weight Watchers International (NASDAQ: WW ) +40% . Paratek Pharmaceuticals (NASDAQ: PRTK ) +35% . Owens & Minor (NYSE: OMI ) +29% . Match Group (NASDAQ: MTCH ) +27% . SolarEdge Technologies (NASDAQ: SEDG ) +24% . Guardant Hea...

NEW YORK, Aug. 07, 2019 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, is investigating whether the sale of Cambrex Corporation   (NYSE: CBM) to an affiliate of the Permira funds (“Permira”) for $60.00 per share is fair to Cambrex shareholders. O...